High Pointe Capital Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

High Pointe Capital Management’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-82,740	Closed	-$320K	–	178
2015 Q1	$320K	Sell	82,740 -18,110	-18%	-$67.1K	0.11%	154
2014 Q4	$364K	Sell	100,850 -12,650	-11%	-$33.5K	0.16%	147
2014 Q3	$302K	Hold	113,500	–	–	0.13%	159
2014 Q2	$1.32M	Buy	+113,500	New	+$1.29M	0.48%	98

Other funds holding MBII

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

High Pointe Capital Management's MBII Position: Q2 2015 in Review

High Pointe Capital Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2015, closing a stake of 82,740 shares — an estimated $320K sold.

High Pointe Capital Management first reported a position in MBII in Q2 2014 and held it in 4 quarters. The position peaked at $1.32M in Q2 2014. 38 funds tracked by Wall St. Rank hold MBII as of Q2 2015.

High Pointe Capital Management reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2015 after selling out during the quarter.
High Pointe Capital Management sold 82,740 Marrone Bio Innovations, Inc. shares in Q2 2015, an estimated $320K.
High Pointe Capital Management first reported a position in Marrone Bio Innovations, Inc. in Q2 2014 and held it in 4 quarters.
High Pointe Capital Management's Marrone Bio Innovations, Inc. position peaked at $1.32M in Q2 2014.
38 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2015.

Based on High Pointe Capital Management's 13F filing for Q2 2015, filed 27 Jul 2015.